| Competitors: | Synthes Acc.Inv. Sf-,001, Stryker, Johnson & Johnson, Zimmer Biomet Holdings Inc |
| Registrars: | Equiniti |
| Brands: | profix, cofield |
| Independent Non-Executive Director: | Simon Lowth |
| CEO: | Deepak Nath |
| CFO: | John Rogers |
| Independent Non-Executive Director: | Sybella Stanley |
| Independent Non-Executive Director: | Jeremy (Jez) Maiden |
| Independent Non-Executive Director: | Jo Hallas |
| Independent Non-Executive Director: | David King |
| Independent Non-Executive Director: | Katarzyna Mazur Hofsaess |
| Independent Non-Executive Director: | Garheng Kong |
| Independent Non-Executive Director: | John Ma |
| Non-Executive Chairman: | Rupert Soames |
| Senior Independent Director: | Angie Risley |
| Non-Executive Dir: | Marc Owen |
| Address: | Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, United Kingdom, WD18 8YE |
| Phone: | +44 (0)1923 477 100 |
| Fax: | +44 (0) 20 7960 2350 |
| Website: | http://www.smith-nephew.com |
| Sector: | Health Care(LSE) |
| Index: | techMARK, FTSE 100, FTSEurofirst 300, FTSE 350, FTSE All-Share, FTSE techMARK Focus |
| Overseas Listings: | BATSLON:SNL |
| ISIN: | GB0009223206 |
| Currency | UK Pounds |
| Share Price | 1,405.00p |
| Change Today | 38.00p |
| % Change | 2.78 % |
| 52 Week High | 1,435.00p |
| 52 Week Low | 917.60p |
| Volume | 2,178,297 |
| Shares Issued | 848.58m |
| Market Cap | £11,922m |
| Beta | 0.93 |
| RiskGrade | 173 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 3 |
| Neutral | 9 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 16 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 02-Oct-25 | 27-Mar-25 |
| Paid | 07-Nov-25 | 28-May-25 |
| Amount | 15.00¢ | 23.10¢ |
| Time | Volume / Share Price |
| 16:48 | 75 @ 1,405.00p |
| 16:40 | 1,771 @ 1,405.00p |
| 16:40 | 689 @ 1,405.00p |
| 16:40 | 321 @ 1,405.00p |
| 16:35 | 2,816 @ 1,405.00p |
| CEO | Deepak Nath |
| CFO | John Rogers |
You are here: research